Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region

被引:68
作者
Ceran, Nurgul [1 ]
Turkoglu, Recai
Erdem, Ilknur [1 ]
Inan, Asuman [1 ]
Engin, Derya [1 ]
Tireli, Hulya
Goktas, Pasa [1 ]
机构
[1] Haydarpasa Numune Training & Res Hosp, Dept Infect Dis, Istanbul, Turkey
关键词
neurobrucellosis; serology; diagnosis; neuroimaging; NERVOUS-SYSTEM BRUCELLOSIS; CIPROFLOXACIN; ANTIBODIES; ABSCESS;
D O I
10.1590/S1413-86702011000100010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Brucellosis is a zoonotic infection and has endemic characteristics. Neurobrucellosis is an uncommon complication of this infection. The aim of this study was to present unusual clinical manifestations and to discuss the management and outcome of a series of 18 neurobrucellosis cases. Initial clinical manifestations consist of pseudotumor cerebri in one case, white matter lesions and demyelinating syndrome in three cases, intracranial granuloma in one case, transverse myelitis in two cases, sagittal sinus thrombosis in one case, spinal arachnoiditis in one case, intracranial vasculitis in one case, in addition to meningitis in all cases. Eleven patients were male and seven were female. The most prevalent symptoms were headache (83%) and fever (44%). All patients were treated with rifampicin, doxycycline plus trimethoprim-sulfamethoxazole or ceftriaxone. Duration of treatment (varied 3-12 months) was determined on basis of the CSF response. In four patients presented with left mild sequelae including aphasia, hearing loss, hemiparesis. In conclusion, although mortality is rare in neurobrucellosis, its sequelae are significant. In neurobrucellosis various clinical and neuroradiologic signs and symptoms can be confused with other neurologic diseases. In inhabitants or visitors of endemic areas, neurobrucellosis should be kept in mind in cases that have unusual neurological manifestations.
引用
收藏
页码:52 / 59
页数:8
相关论文
共 29 条
[1]  
Adaletli I, 2006, AM J NEURORADIOL, V27, P384
[2]   Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis [J].
Agalar, C ;
Usubutun, S ;
Turkyilmaz, R .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (08) :535-538
[3]   Central nervous system brucellosis:: Presentation, diagnosis and treatment [J].
Akdeniz, H ;
Irmak, H ;
Anlar, Ö ;
Demiröz, AP .
JOURNAL OF INFECTION, 1998, 36 (03) :297-301
[4]  
Al-Sous MW, 2004, AM J NEURORADIOL, V25, P395
[5]   CEFTRIAXONE IN THE TREATMENT OF ACUTE AND SUBACUTE HUMAN BRUCELLOSIS [J].
ALIDRISSI, HY ;
UWAYDAH, AK ;
DANSO, KT ;
QUTUB, H ;
ALMOUSA, MS .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1989, 17 (04) :363-368
[6]   BRUCELLA MENINGITIS [J].
ALORAINEY, IO ;
LAAJAM, MA ;
ALASKA, AK ;
RAJAPAKSE, CN .
JOURNAL OF INFECTION, 1987, 14 (02) :141-145
[7]   RAPID DIAGNOSIS OF CENTRAL-NERVOUS-SYSTEM BRUCELLOSIS BY ELISA [J].
ARAJ, GF ;
LULU, AR ;
SAADAH, MA ;
MOUSA, AM ;
STRANNEGARD, IL ;
SHAKIR, RA .
JOURNAL OF NEUROIMMUNOLOGY, 1986, 12 (03) :173-182
[8]   Detection of antibodies to Brucella cytoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis [J].
Baldi, PC ;
Araj, GF ;
Racaro, GC ;
Wallach, JC ;
Fossati, CA .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (05) :756-759
[9]   NERVOUS-SYSTEM BRUCELLOSIS - DIAGNOSIS AND TREATMENT [J].
BASHIR, R ;
ALKAWI, MZ ;
HARDER, EJ ;
JINKINS, J .
NEUROLOGY, 1985, 35 (11) :1576-1581
[10]   CHRONIC NEUROBRUCELLOSIS DUE TO BRUCELLA-MELITENSIS [J].
BUCHER, A ;
GAUSTAD, P ;
PAPE, E .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1990, 22 (02) :223-226